Use of Adherence Monitoring in Drug Contracts Tied to Outcomes: Put Patients First
BMJ
Authors
Theodore Bartholomew, Huseyin Naci, Emma Robertson, Harald Schmidt
CHIBE Experts
Research Areas
You might also be interested in...
View all publications-
Buprenorphine-Precipitated Withdrawal Among Hospitalized Patients Using Fentanyl
JAMA Network OpenSeptember 27, 2024 -
Skepticism Calibration Disorder—The New Public Health Crisis
JAMA Network OpenSeptember 4, 2024 -
Clinician Specialty and HIV PrEP Prescription Reversals and Abandonments
JAMA NetworkAugust 19, 2024 -
Using machine learning to unveil relevant predictors of adherence to recommended health-protective behaviors during the COVID-19 pandemic in Denmark
International Association of Applied PsychologyJune 8, 2024 -
Remote Blood Pressure Monitoring With Social Support for Patients With Hypertension: A Randomized Clinical Trial
JAMA Network OpenJune 3, 2024 -
Participant perspectives on incentives for TB preventative therapy adherence and reduced alcohol use: A qualitative study
PLOS Global Public HealthApril 24, 2024 -
B-OK: A Visual and Tactile Tool for HIV Treatment Adherence Support in a United States Urban Center
medRxivMarch 1, 2024 -
Association Between Self-Reported Medication Adherence and Therapeutic Inertia in Hypertension: A Secondary Analysis of SPRINT (Systolic Blood Pressure Intervention Trial)
Journal of the American Heart AssociationJanuary 19, 2024 -
Pilot Study of a Mobile Phone Chatbot for Medication Adherence and Toxicity Management Among Patients With GI Cancers on Capecitabine
JCO Oncology PracticeJanuary 18, 2024 -
Estimating The Impact Of Out-Of-Pocket Cost Changes On Abandonment Of HIV Pre-Exposure Prophylaxis
Health AffairsJanuary 8, 2024 -
Detection of Medication Taking Using a Wrist-Worn Commercially Available Wearable Device
JCO Clinical Cancer InformaticsDecember 21, 2023 -
Financial Incentives for Reduced Alcohol Use and Increased Isoniazid Adherence During Tuberculosis Preventive Therapy Among People With HIV in Uganda: An Open-Label, Factorial Randomised Controlled Trial
The Lancet Global HealthDecember 1, 2023